Last update :
18/04/2024
Anticancer drug   Daunorubicin/cytarabine liposomale  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Vyxeos France, Germany, Great Britain, United States of America
Stability in solutions   Injection   Stability in solutions : Daunorubicin/cytarabine liposomale     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 2.2 / 5 mg/mL 2-8°C Not specified
4 Hour
4355
Manufacturer's stability data

Glass Water for Injection 2.2 / 5 mg/mL 2-8°C Not specified
4 Hour
4355
Manufacturer's stability data

Polyolefine NaCl 0,9% or Glucose 5% 0.087 / 0.195 mg/mL 2-8°C Not specified
4 Hour
4355
Manufacturer's stability data

Polyolefine NaCl 0,9% or Glucose 5% 0.176 / 0.4 mg/mL 2-8°C Not specified
4 Hour
4355
Manufacturer's stability data


  Mentions Légales